4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickie, BG; Greenfield, SA | 1 |
1 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
Chronic exposure to Ro20-1724 protects dopaminergic neurons in vitro against the neurotoxic action of N-methyl-D-aspartate and 1-methyl-4-phenylpyridinium.
Topics: 1-Methyl-4-phenylpyridinium; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Dopamine; Dopamine Agents; N-Methylaspartate; Neurons; Neuroprotective Agents; Neurotoxins; Phosphodiesterase Inhibitors; Rats; Time Factors | 1997 |